Page last updated: 2024-08-21

diphenylamine and Carcinoma, Large Cell

diphenylamine has been researched along with Carcinoma, Large Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bazhenova, L; Cohen, RB; Eisenberg, PD; Gadgeel, SM; Haura, EB; Larson, TG; Miller, VA; Ricart, AD; Selaru, P; Stella, PJ; Wilner, KD	1

Trials

1 trial(s) available for diphenylamine and Carcinoma, Large Cell

Article	Year
A phase II study of PD-0325901, an oral MEK inhibitor, in previously treated patients with advanced non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, Apr-15, Volume: 16, Issue:8 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Benzamides; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Diphenylamine; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitogen-Activated Protein Kinase Kinases; Survival Rate; Tissue Distribution; Treatment Outcome	2010

Article

Year

A phase II study of PD-0325901, an oral MEK inhibitor, in previously treated patients with advanced non-small cell lung cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, Apr-15, Volume: 16, Issue:8

Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Benzamides; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Diphenylamine; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitogen-Activated Protein Kinase Kinases; Survival Rate; Tissue Distribution; Treatment Outcome

2010